INTRODUCTION
============

*Candida* osteomyelitis is a chronic form of invasive osteomyelitis. It causes significant morbidity if not recognized early or treated effectively \[[@b1-acfs-2020-00136],[@b2-acfs-2020-00136]\] and may persist for months \[[@b3-acfs-2020-00136]\]. Depending on the mechanism of development, *Candida* osteomyelitis can be classified as (1) direct inoculation: seeding of bone tissue by external trauma, open wound, ulcer, or surgical manipulation; (2) contiguous infection: the presence of an infectious *Candida* process close to the subsequently infected bone; or (3) hematogenous infection: seeding of bone tissue by bloodstream route in the absence of contiguous or direct inoculation. Infantile osteomyelitis is an uncommon and life-threatening disease. Etiological considerations may include infective pathogenesis, genetic disorders, toxins, and/or environmental factors. Here, we report a rare case of a 9-month-old male infant diagnosed with infantile osteomyelitis secondary to *Candida* infection.

CASE REPORT
===========

A 9-month-old male infant referred to our center with palatal fistula secondary to a pathological condition. Antenatal history revealed a male neonate of 3.5 kg was delivered vaginally in the 39th week of gestation with no perinatal or postnatal complications. After standard postdelivery care, the baby was healthy at the time of discharge. The baby was admitted to the hospital when he was one and a half months old with a complaint of discharging sinus from the right cheek and whitish scrapable patches over his cheek and palate. Incision and drainage were performed extraorally, and culture swab was taken for examination. Bone biopsy was done from the palatal region, and the bone was exposed. Microscopic examination suggested areas of osteolysis, yeast-like fungus, and *Candida utilis* grew on cultures of the bone specimen. Culture swab reported the presence of a non-albican *Candida, C. utilis*. After the patient was treated with antifungal therapy (liposomal amphotericin B) for one and a half months, the baby improved clinically.

Then the patient presented to our center with a chief complaint of nasal regurgitation and feeding problems. Clinical examination identified an obvious deformity of the middle third of the face ([Fig. 1](#f1-acfs-2020-00136){ref-type="fig"}). These findings were confirmed on a threedimensional reconstructive computed tomography, which also showed the destruction of maxilla, including a part of the nasal bone ([Fig. 2](#f2-acfs-2020-00136){ref-type="fig"}). Intraoral examination revealed a large-sized, ovalshaped anterior palatal fistula with no inflammatory signs ([Fig. 3](#f3-acfs-2020-00136){ref-type="fig"}). Deciduous teeth were absent with no maxillary alveolar arch. Depending on the history, culture report, and clinical and radiographical findings, a definitive diagnosis of *Candida* osteomyelitis was made. Maxillary reconstruction was not recommended as the patient's age was less than a year. We planned closure of the palatal fistula to overcome his present problems like feeding and nasal regurgitation. The patient was operated under general anesthesia. No signs of fibrosis were observed. The nasal layer was repaired, and the marking of posteriorly based myo-mucosal buccal flaps was done. ([Fig. 4](#f4-acfs-2020-00136){ref-type="fig"}). Bilateral buccal flaps were taken, along with a buccal fat pad, to cover the nasal layer and facilitate the closure ([Figs. 5](#f5-acfs-2020-00136){ref-type="fig"}, [6](#f6-acfs-2020-00136){ref-type="fig"}). Complete closure was achieved ([Fig. 7](#f7-acfs-2020-00136){ref-type="fig"})

DISCUSSION
==========

*Candida* osteomyelitis causes significant morbidity. Prior et al. \[[@b4-acfs-2020-00136]\] reported that *C. utilis* has long been known for its industrial applications, but it has rarely been described as an infectious agent in humans \[[@b5-acfs-2020-00136]-[@b7-acfs-2020-00136]\]. It is characterized by a chronic course with a male predominance. Hematogenous dissemination is the most common mechanism involved with this infection, followed by direct inoculation and contiguous infection. Based on age, the common sites for pediatric patients are the femur, humerus, and vertebra/ribs. The costal cartilage, costochondral joints, knees, and sacroiliac joint are the other usual sites. Maxillofacial bones are less commonly affected by *Candida* osteomyelitis. Gamaletsou et al. \[[@b8-acfs-2020-00136]\] conducted a study in 2012 and analyzed 207 pediatric and adult cases (1970--2011) of *Candida* osteomyelitis and concluded that timely diagnosis of *Candida* osteomyelitis with extended courses of 6--12 months of antifungal therapy and surgical intervention may improve the outcome of the disease. The study also documented the importance of relapse despite treatment, possibly as a result of inadequate duration of therapy.

Risk factors for candidemia in neonates and infants include umbilical vein catheterization, very low birth weight, necrotizing enterocolitis, localizing osteoarticular symptoms, etc. In our case, there was no such history and the baby's weight was 3.5 kg. Predisposing factors also include the usage of antineoplastic agents and the immunocompromised status of the patient. Compromised immunity might be the causative factor in our patient.

Gathe et al. \[[@b1-acfs-2020-00136]\] reported five cases of *Candida* osteomyelitis and employed successful therapeutic regime. They suggested the combination of antifungal therapy (most often amphotericin B) with surgical debridement. They also proposed that amphotericin B should be considered as the drug of choice until controlled studies demonstrate the superiority of the other agents in deep-seated *Candida* infection. Andermahr et al. in 1988 \[[@b9-acfs-2020-00136]\] reported a case of *Candida* tropicalis spondylitis L I and L II with *Candida* coxitis and used the combination of antifungal therapy (amphotericin B or fluconazole) with radical surgical debridement for the treatment. Similarly, in our case, liposomal amphotericin B was prescribed for one and a half months parenterally. Arranz-Caso et al. in 1996 \[[@b10-acfs-2020-00136]\] reported a case of zygomatic candidiasis osteomyelitis in an adult patient with history of diabetes and oral candidiasis. He reported that fluconazole was ineffective, and amphotericin B was proven to be successful in the treatment.

In our case, *Candida* osteomyelitis affects complete maxillary bone and the aggressiveness of the infection was so destructive that it involved the maxillary alveolar process along with the basal bone and a part of nasal bone in the acute course of duration.

To conclude, *Candida* osteomyelitis affecting maxillofacial bones is a rare entity, and very few cases have been reported in the literature. Early diagnosis and prompt treatment can reduce the incidence of the sequel.
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